Mehmet Hilmi Dogu

InstitutionIstanbul Training and Research Hospital
AddressIstanbul
Turkey
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 2 publications in August 2020 and Spetember 2020 and October 2020
    All Publications
    Bar chart showing 36 publications over 10 distinct years, with a maximum of 9 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dal MS, Ata N, Altuntas F, Basci S, Yigenoglu TN, Korkmaz S, Namdaroglu S, Bastürk A, Hacibekiroglu T, Dogu MH, Berber I, Dal K, Erkurt MA, Turgut B, Çaglayan M, Imrat E, Çelik O, Ülgü MM, Birinci S. COVID-19 clinical course and blood groups: Turkish population-based study Turk J Med Sci. 2021 08 30; 51(4):1659-1664. PMID: 33957720.
      Citations: 2     Fields:    Translation:Humans
    2. Basci S, Ata N, Altuntas F, Yigenoglu TN, Dal MS, Korkmaz S, Namdaroglu S, Bastürk A, Hacibekiroglu T, Dogu MH, Berber I, Dal K, Erkurt MA, Turgut B, Çelik O, Ülgü MM, Birinci S. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Intern Emerg Med. 2022 01; 17(1):135-139. PMID: 34110562.
      Citations:    Fields:    
    3. Altuntas F, Ata N, Yigenoglu TN, Basci S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacibekiroglu T, Dogu MH, Berber I, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Akunal A, Birinci S. COVID-19 in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2021 04; 56(4):952-955. PMID: 33110186.
      Citations: 3     Fields:    Translation:Humans
    4. Serin I, Ulusoy A, Onar MI, Dogu MH. COVID-19 Pneumonia or Hypereosinophilic Syndrome? J Med Cases. 2020 Dec; 11(12):400-402. PMID: 33984086.
      Citations:    
    5. Serin I, Sari ND, Dogu MH, Acikel SD, Babur G, Ulusoy A, Onar MI, Gokce EC, Altunok O, Yaylaci Mert F, Karakilic A, Baltik M, Gulesir B. A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality. J Infect Public Health. 2020 Nov; 13(11):1664-1670. PMID: 33071210.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    6. Altuntas F, Ata N, Yigenoglu TN, Basci S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacibekiroglu T, Dogu MH, Berber I, Dal K, Kinik K, Haznedaroglu I, Yilmaz FM, Kiliç I, Demircioglu S, Yosunkaya A, Erkurt MA, Turgut B, Caglayan M, Celik O. Convalescent plasma therapy in patients with COVID-19. Transfus Apher Sci. 2021 Feb; 60(1):102955. PMID: 33011076.
      Citations: 17     Fields:    Translation:Humans
    7. Basci S, Ata N, Altuntas F, Yigenoglu TN, Dal MS, Korkmaz S, Namdaroglu S, Bastürk A, Hacibekiroglu T, Dogu MH, Berber I, Dal K, Erkurt MA, Turgut B, Çaglayan M, Ayvali MO, Çelik O, Ülgü MM, Birinci S. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract. 2020 Oct; 26(7):1676-1682. PMID: 32854573.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    8. Yigenoglu TN, Ata N, Altuntas F, Basci S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacibekiroglu T, Dogu MH, Berber I, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Imrat E, Birinci S. The outcome of COVID-19 in patients with hematological malignancy. J Med Virol. 2021 02; 93(2):1099-1104. PMID: 32776581.
      Citations: 13     Fields:    Translation:Humans